Tryptamine Therapeutics Ltd

ASX:TYP (Australia)   Ordinary Shares
A$ 0.02 (+4.76%) Jun 7
At Loss
P/B:
1.47
Market Cap:
A$ 26.15M ($ 17.25M)
Enterprise V:
A$ 26.04M ($ 17.17M)
Volume:
917.58K
Avg Vol (2M):
6.98M
Volume:
917.58K
At Loss
Avg Vol (2M):
6.98M

Tryptamine Therapeutics Ltd Valuation Measures